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The metabolic mechanisms underlying the development of exaggerated fear in post-
traumatic stress disorder (PTSD) are not well defined. In the present study, alteration
in the expression of genes associated with mitochondrial function in the amygdala of an
animal model of PTSD was determined. Amygdala tissue samples were excised from 10
non-stressed control rats and 10 stressed rats, 14 days post-stress treatment. Total RNA
was isolated, cDNA was synthesized, and gene expression levels were determined using a
cDNA microarray. During the development of the exaggerated fear associated with PTSD,
48 genes were found to be significantly upregulated and 37 were significantly downreg-
ulated in the amygdala complex based on stringent criteria (p<0.01). Ingenuity pathway
analysis revealed up- or downregulation in the amygdala complex of four signaling net-
works – one associated with inflammatory and apoptotic pathways, one with immune
mediators and metabolism, one with transcriptional factors, and one with chromatin remod-
eling. Thus, informatics of a neuronal gene array allowed us to determine the expression
profile of mitochondrial genes in the amygdala complex of an animal model of PTSD. The
result is a further understanding of the metabolic and neuronal signaling mechanisms
associated with delayed and exaggerated fear.
Keywords: PTSD, amygdala, mitochondrial genes, stress, fear, Bcl-2, microarray
INTRODUCTION
The neurobiology of exaggerated fear is important in understand-
ing traumatic stress and post-traumatic stress disorder (PTSD).
Decades of animal studies have shown that the amygdala is key
in the neuronal system that orchestrates the fear memory and
exaggerated fear evoked by stress. In PTSD patients exposed to an
aversive visual stimulus or a fear inducing pulse of sound, fMRI
shows an increased blood flow and metabolic rate in the amyg-
dala, indicating a prolonged dysregulation of metabolism and an
altered neuronal transmitter system in the amygdala circuitry (1–
3). Dysregulation appears to persist throughout life, at least in the
frontal cortex, as we found by analyzing a mitochondria gene array
from post-mortem frontal cortex samples of PTSD patients. Genes
and signaling pathways, as well as pharmacological targets, were
significantly dysregulated (4).
Mitochondria are targets for stress hormones such as corti-
costerone (CORT) and are increasingly recognized as key com-
ponents in stress-related mental disorders (5, 6). Prolonged and
repetitive psychological stress can induce long-lasting neurobio-
logical consequences. However, the exact subcellular mechanisms
involved in such long-term neuronal and hormonal impairment
remain elusive. The current study used a rat model of PTSD
to further examine amygdala function and traumatic stress. In
this study, we examined the relationship of altered amygdala
mitochondrial-function genes and the molecular signaling path-
ways associated with a key symptom of PTSD: delayed and exag-
gerated fear. Amygdala tissues were collected from rats 14 days
after stress, a time point at which exaggerated fear manifests. We
then screened for 1500 mitochondrial-function-associated genes,
including 37 mitochondrial DNA (mtDNA)-encoded genes, 1,098
nuclear DNA (nDNA)-encoded and mitochondria-focused genes,
and 365 neuron-related genes (7, 8).
Up until now, the altered subcellular and metabolic molecu-
lar markers associated with delayed and exaggerated fear in the
amygdala were unknown. Thus, this research was carried out in an
attempt to determine whether traumatic stress alters the expres-
sion profiles of mitochondrial genes in association with the patho-
genesis of delayed and exaggerated fear. A mitochondrial microar-
ray technique was used to examine all mitochondrial-function-
associated transcriptomes and to map the susceptible gene clusters
in the amygdala complex associated with delayed and exagger-
ated fear. Our results indicate that signaling pathways, includ-
ing pre-inflammatory, apoptotic, metabolic, neuronal transmitter
system, and genes of G-protein-coupled receptors are up- or
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downregulated 14 days after the stress paradigm. The impacts
of alteration in regulation of these molecular mechanisms are
discussed below.
MATERIALS AND METHODS
ANIMAL MODEL OF PTSD
The animal model of PTSD employs restraint and tail shocks on
three consecutive days. This inescapable tail-shock model (ITS)
in rats mimics in many ways the pathophysiology of PTSD (9–
13). In our model, stress exposure consists of a daily 2-h session
of immobilization and tail-shocks for three consecutive days. The
animals are restrained in Plexiglas tubes, and 40 electric shocks
(2 mA, 3 s duration) are applied at varying intervals (140–180 s).
Animals thereby undergo an aversive experience under condi-
tions in which they cannot adaptively respond. We and others
have verified that the ITS model induces behavioral and neu-
robiological alterations similar to those found in PTSD subjects
(9–12). Specifically, these stressed rats exhibit (1) a delayed and
exaggerated startle response appearing several days after stres-
sor cessation which, given the compressed time scale of the rat’s
life compared to a humans, corresponds to the 1–3 months delay
of symptoms in PTSD patients (14, 15), (2) enhanced plasma
CORT for several days, indicating a compromised hypothalamopi-
tuitary axis (HPA), and (3) retarded body weight gain after stressor
cessation, indicating dysfunction of gene expression. The gene
expression microarray used in this experiment, dubbed the rat
mitochondrion-neuron focused microarray (rMNChip), focuses
on mitochondrial and mitochondria-related nuclear genes in the
rat so as to specifically address the neuronal bioenergetics hypoth-
esized to be involved in arousal, CORT, and growth as addressed
in our model of PTSD (13).
Male albino Sprague Dawley rats were used (Taconic Farms,
Derwood, MD, USA), weighing 150–200 g at the time of adminis-
tration of the stress protocol. Two groups of animals (n= 20) were
studied. Twenty animals were assigned to each group based on
their body weight and baseline startle response. Group 1 received
the stress protocol, and Group 2 was the control. Stress exposure
consisted of a daily 2-h session of restraint by immobilization
in ventilated Plexiglas tubes (“inescapable”) and tail shocks for
three consecutive days. Stressing was performed in the morning
(between 08:00 and 12:00 hours).
Forty electric shocks (2 mA, 3 s duration; Animal Test Cage
Grid Floor Shocker, Coulbourn Instruments, USA) were delivered
to the tail of Group 1 rats at semi-random intervals of 150–210 s
(Graphic State Notation Software, Habitest Universal Link, Coul-
bourn Instruments, USA). Electrode gel was applied using Q-tips
to form a thin layer of conducting gel between the electrode and
the skin of the rat’s tail. The electrode clips were adjusted and con-
nected to the tail to ensure a good connection without affecting the
blood circulation of the tail. Amygdala dissection was performed
as previously described (13).
RAT MITOCHONDRIA NEURONAL CHIP
The rMNChip was designed and fabricated by GenProMarkers,
Inc. (Rockville, MD, USA) using published methods (8). Briefly,
the rMNChip contains 1,500 genes, including 37 mtDNA-encoded
genes, 1,098 nDNA-encoded and mitochondria-focused genes,
and 365 genes associated with neuronal functions, including fear
response, circadian rhythms, intraneuronal signal transduction,
and neurotransmitters. The oligonucleotides used were designed
with the software MacVector v10.6.0 (MacVector) using full-length
mRNA sequences as the templates according to published cri-
teria. An amino-C6 modifier was added to the 5′-end of each
oligonucleotide probe to enhance the binding of the DNA to glass
slides and the accessibility of hybridization with target DNA. The
1,500 test genes (including 80 “housekeeping” genes as positive
controls) and 36 negative controls (non-rat DNA) were printed,
each in triplicates, onto the N -hydroxysuccinimide ester reactive
group-coated glass slides (CodeLink Activated Slide, SurModics,
Eden Prairie, MI, USA). DNA probes in the print buffer (50 mM
sodium phosphate), at a final concentration of 20µM of 5′-amino-
C6 modified 50-mers, were printed in the Class 100 super-clean
environment as described previously (7, 16, 17), using 100µM
pins and the GeneMachine OmniGrid 100 Microarrayer (Genomic
Solutions, Ann Arbor, MI, USA).
RNA PURIFICATION
Total cellular RNA was purified from rat brain tissues by using a
PAXgene RNA Kit (QIAGEN Inc., Valencia, CA, USA) following
the manufacturer’s instructions. The amygdalas of rats from both
the stress and control groups were dissected immediately after
euthanasia (13).
MICROARRAY HYBRIDIZATION
One microgram of RNA per sample was used for Cy5dUTP label-
ing of cDNA by use of the express array detection kit (3DNA
Array 900, Genisphere, Hatfield, PA, USA) following the manufac-
turer’s instructions. Slides were scanned using 5µM resolution
and the LOWESS method with a ScanArray Microarray Scan-
ner (PerkinElmer). Triplicate microarray experiments were per-
formed for each RNA sample purified from the amygdala. The
background-subtracted mean values of the measured gene expres-
sion signal intensities were used for microarray data analysis. All
microarray experiments were performed in the same laboratory
as GenProMarkers, Inc. (8).
MICROARRAY DATABASE, BIOINFORMATICS, AND SYSTEMS BIOLOGY
A gene expression database was constructed using FileMaker
software (FileMaker Pro, Inc., Santa Clara, CA, USA). Database
construction, data filtering, selection, exclusion and inclusion pro-
cedures, and criteria were performed as described previously (7,
8). The quantile normalization method (18) in software R ver-
sion 2.15.1 (The R Foundation for Statistical Computing) was
used to normalize background-subtracted mean intensities across
all intra- and inter-slides of informative microarray data. Cor-
relation and Single linkage methods were used to cluster and to
make the heatmap using Cluster version 3.0 and MapleTree soft-
wares1. The normalized data were also used for the calculation of
means, SD, fold changes, moderated p-values, and false discovery
rates (FDR). Gene IDs, official symbols, and official full names
were updated using the NCBI database2. Kyoto Encyclopedia of
1http://rana.lbl.gov/EisenSoftware.htm
2www.ncbi.nlm.nih.gov/gene
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Genes and Genomes (KEGG) pathways and Online Mendelian
Inheritance in Man (OMIM) were from DAVID Bioinformatics
Resources3.
STATISTICS
The quantile normalization method (18) in software R/Biocon-
ductor version 2.15.1 (The R Foundation for Statistical Comput-
ing) was used to normalize data. Means,SDs,and fold changes were
calculated from triplicate spots (Amygdala complex) and triplicate
experiments using XLSTAT 2006 (XLSTAT, New York, NY, USA).
Differentially expressed genes were identified arbitrarily as hav-
ing a greater than twofold change in the average expression of the
background-subtracted mean intensity ratios of a gene between
comparisons (19). The moderated p-values and FDR for multi-
ple statistical testing with Benjamini and Hochberg methods (20)
were calculated with the software R/Bioconductor version 2.15.1
(The R Foundation for Statistical Computing). The level of statis-
tical significance was set at a p-value <0.01 with a specific FDR
indicated. The error bar and plot were generated using Origin Lab
version 8.5.
EXPERIMENTAL PARADIGM (FIGURE 1)
FIGURE 1 | Diagrammatic representation of the animal stress protocol.
Amygdala complex (A) from control group (n=10) and stressed group
(n=10) were dissected 14 days after cessation of 3 days stress (S).
RESULTS
HEATMAP PRESENTATION FOLLOWING MICROARRAY DATA
COLLECTION AND ANALYSIS
The amygdala tissues were dissected from the rat brain 14 days
after the cessation of the 3 days of stress. Total RNA samples were
extracted from the amygdala complex of stressed rats (n= 10), and
controls (n= 10) (13). Microarray experiments were triplicated
using our recently developed fourth generation rat mitochondria-
focused cDNA chip rMitChip3. With three spots in one cDNA
microarray chip and three chips per each amygdala sample, the
resulting analysis of nine data values from each single speci-
men greatly reduces misclassification rates (8). The measurement
of expression of individual genes on the rMitChip3 (rMNChip)
in one group was analyzed using 90 values (3 identical probes
per microarray, 3 microarray experiments per specimen, and
10 specimens per gene), which generated reliable expression
data for further pathway analysis. In this present study, the
mitochondria-focused gene expression profilings in the amygdala
3http://david.abcc.ncifcrf.gov
complex 14 days after traumatic stress were analyzed using the
cDNA microarray chip containing 1500 genes associated with
mitochondria functions. Based on the unsupervised cluster results,
we calculated the average expression level of each gene in the
stressed group (n= 10) and in the non-stressed control group
(n= 10). The microarray data of 270,000 spots across all 60
microarray chips used for 20 RNA samples were filtered by uni-
form statistic and bioinformatic criteria (7), which generated 85
genes with informative expression profiles.
We identified a cluster and heatmap of 85 genes with signifi-
cantly expressed RNA derived from the amygdala complex of the
10 control rats and the 10 stressed rats (Figure 2). The resultant
dendrograms for all of these 85 genes and 20 amygdala complex
specimens are classified as control group from CON-01 to CON-10
and stressed group from STR-1 to STR-10 in Figure 2; these analy-
ses separated the stressed amygdala from those of the controls by
their gene expression profiles. Figure 2A reveals 37 downregulated
gene profiles and Figure 2B reveals 48 upregulated gene profiles.
PATHWAY ANALYSIS OF UP- AND DOWNREGULATED GENES
Pathways containing protein products of the up- and downregu-
lated genes were determined using the Ingenuity Pathway Analysis
(IPA) program. Table 1 illustrates the 34 upregulated genes and
21 downregulated genes in the amygdala after stress. A high strin-
gency algorithm was used, including fold changes and FDR com-
paring stressed to controls (Tables 1 and 2). The tables include
gene symbols, full names of genes listed in Genecards, fold change
[ratio of stress and control, log(2) of the ratio], p-value, and fault
discover rate (FDR).
Molecular networks associated with mitochondrial functions
were constructed based on up- and downregulated genes from
the amygdala complex associated with exaggerated fear (13). Net-
work analysis indicated that four reregulated molecular networks
were associated with metabolic molecules and neurotransmitter
systems, as well as with translational factors in the amygdala com-
plex (Figure 2). Mitochondrial dysfunction involved in endocrine
and neuronal signaling was evident in the amygdala. Detailed
molecular correlations of these reregulated molecular pathways
and the symptoms of PTSD such as exaggerated fear are noted
(Figure 2). The results also suggest possible molecular targets
for pharmacological intervention following exposure to traumatic
stress.
In the network analysis, the networks identified are presented as
graphs indicating the molecular relationships between gene prod-
ucts. Gene products are represented as nodes, and a biological
relationship between two nodes is indicated by a line. The inten-
sity of the node color indicates the degree of upregulation (red)
or downregulation (green). Gene products in uncolored nodes
were not identified as differentially expressed in our experiment,
but were integrated into the computationally generated networks
on the basis of the evidence stored in the IPA knowledge base
indicating a relevance to this network.
The node shapes denote enzymes, phosphates, transmembrane
receptors, cytokines, channels, transcription factors, G-protein-
coupled receptors, growth factors, or nuclear receptor, as shown
in Figure 3. Canonical pathway analysis identified the canonical
pathways from the IPA library that were most significantly related
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FIGURE 2 | Clustering analysis of 48 upregulated and 37 downregulated
genes across all 20 amygdala samples generates double dendrograms
and heat maps that distinguish the stressed amygdala specimens from
the controls (A,B). The identification of these up- and downregulated genes
provides candidates for network analysis. The ratios and p-values (t -test) were
calculated between the stressed (n=10) and control specimens (n=10),
resulting in the identification of 85 genes (p<0.01) and among these 55
altered genes (p<0.01) were further selected using a high stringency
algorithm that includes fold change and fault discovery rate in the stressed
amygdala as compared to the controls (Tables 1 and 2).
to the input data set. The significance of the association between
the data set and the canonical pathway was determined based on
two parameters: (1) a ratio of the number of genes from the data set
that map to the pathway divided by the total number of genes that
map to the canonical pathway and (2) a p-value calculated using
Fischer’s exact test determining the probability that the association
between the genes in the data set, and the canonical pathway is due
to chance alone.
To reveal specific and detailed interactions among up- and
downregulated genes in the amygdala, and to further identify
gene targets for pharmacological agents, four molecular networks
were delineated: (1) Bcl-2 and TNF centered inflammatory and
apoptotic signaling networks as shown in Figure 4; (2) energy
production and neurotransmitter-mediated signaling pathways
as shown in Figure 5; (3) transcriptional factor and chro-
matin remodeling pathways as shown in Figure 6; (4) immune
mediator-related pathways as shown in Figure 7. The genes in
the pathways were selected based on recent literature in the IPA
database and relevance to neurological dysfunction, psychiatric
disorders, and exaggerated fear response associated with amyg-
dala functions as addressed in the Section “Discussion.” Within
these networks, 34 (62%) of the genes were significantly upreg-
ulated (Table 2; Figure 2B) and 21 (38%) of the genes were
significantly downregulated (Table 1; Figure 2A). In the network
analysis, these genes display particular relevance to the symptoms
of PTSD.
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Table 1 | Downregulated genes in amygdala (14 days after stress).
No Gene symbols Names of genes listed in Genecards Fold change Significance
Stress/CON Log(2) p FDR
1 Eef1a2 Eukaryotic translation elongation factor 1 alpha 2 0.22 −2.20 0.0007 0.0044
2 Atp7b ATPase, Cu++ transporting, beta polypeptide 0.31 −1.69 0.0062 0.0129
3 mt−Tl2 Mitochondrially encoded tRNA leucine 2 (CUN) 0.31 −1.68 0.0035 0.0088
4 Bhlhe40 Basic helix-loop-helix family, member e40 0.34 −1.58 0.0006 0.0044
5 Mtch1 Mitochondrial carrier 1 0.35 −1.53 0.0012 0.0047
6 Cyp24a1 Cytochrome P450, family 24, subfamily A, polypeptide 1 0.35 −1.52 0.0145 0.0199
7 Bcl-2 B-cell CLL/lymphoma 2 0.37 −1.42 0.0000 0.0014
8 Bcs1l Mitochondrial chaperone BCS1 0.41 −1.30 0.0079 0.0134
9 Tnf Tumor necrosis factor-alpha 0.42 −1.25 0.0005 0.0044
10 Acot9 Acyl-CoA thioesterase 9 0.44 −1.20 0.0024 0.0071
11 Rnd3 RND3 Rho family GTPase 3 0.44 −1.20 0.0056 0.0122
12 Dhx38 DEAH (Asp–Glu–Ala–His) box polypeptide 38 0.46 −1.13 0.0075 0.0133
13 Bcat2 Branched chain amino-acid transaminase 2, mitochondrial 0.47 −1.09 0.0097 0.0155
14 GDF-15 Growth differentiation factor 15 0.47 −1.08 0.0039 0.0091
15 Flii Flightless I homolog 0.48 −1.06 0.0039 0.0091
16 Gnb4 Guanine nucleotide binding protein (G-protein), beta polypeptide 4 0.48 −1.05 0.0069 0.0133
17 Rrad Ras-related associated with diabetes 0.49 −1.04 0.0041 0.0091
18 Acat1 Acetyl-CoA acetyltransferase 1 0.49 −1.03 0.0146 0.0199
19 Elk3 ETS-domain protein (SRF accessory protein 2) 0.50 −0.99 0.0073 0.0133
20 Phlpp1 PH domain and leucine rich repeat protein phosphatase 1 0.51 −0.97 0.0012 0.0047
21 Plcb2 Phospholipase C, beta 2 0.54 −0.90 0.0103 0.0159
Approved symbol from the HUGO Gene Nomenclature Committee (HGNC) database.
VALIDATION OF THE Rap1b AND Arhgap1 GENE EXPRESSIONS IN THE
AMYGDALA (MICROARRAY) AND BLOOD (qRT-PCR)
Quantitative real-time PCR (qRT-PCR) was used to validate and to
confirm gene expression results obtained from microarray analy-
sis in our previous published results (4). The relative mRNA levels
of identified genes measure by qRT-PCR were in agreement with
the data detected by microarray from 92 to 67% on five genes
examined (4). In an attempt to correlate biomarkers in peripheral
tissue (blood) with the profile of dysregulated genes in the amyg-
dala, Rap1b and Arhgap1 were chosen in the current study because
of upregulation of (Rap1b) and downregulation of (Arhgap1)
expressions observed in stressed amygdala and blood as well as
because Rap1b is of known relevance to abnormal fear response
(21). The results show that the relative mRNA levels of these genes
measured by qRT-PCR (blood, n= 8, p< 0.01) were in agree-
ment with the data detected by microarray (amygdala, n= 10,
p< 0.01) experiments (shown in Figures 1A,B in Supplementary
Material).
DISCUSSION
Animal models of PTSD offer opportunities to identify mecha-
nisms, potential biomarkers, and treatment targets for this dis-
order. In this study, we have shown that a substantial number
of up- and downregulated genes related to mitochondrial func-
tion in the amygdala are associated with an animal model of
PTSD based on exaggerated startle and retardation of growth (9,
13). These mitochondrial-function genes have been previously
related to neurological dysfunction, psychiatric disorders, and
stress response (4, 6). In addition, we have identified novel
mitochondrial-function-related genes associated with endocrine
and neuronal signaling (4, 5, 22).
Traumatic stress up- or downregulation of anti-inflammatory
and anti-apoptotic cellular pathways are evidenced in the amyg-
dala 14 days after stress, as indicated in Figure 4 and Tables 1 and
2. Seven genes, including RAP1B, Cathepsin D (CTSD), MKNK1,
RASGRP, CSF2RB, GMCSF, and CFLAR are upregulated and nine
genes, including tumor necrosis factor (TNF), Bcl-2, GDF-15, early
growth response (Egr1), GNB, FLII, BHLHE40, RND3, and GNB4
are downregulated in the inflammatory and apoptotic signaling
networks in the amygdala.
Levels of inflammatory cytokines in blood samples have been
used as biomarkers of PTSD vulnerability and resilience in trauma-
tized individuals (23–26). TNF-α and related anti-inflammatory
cytokines in the peripheral blood have been correlated with symp-
toms of PTSD, including re-experiencing, avoidance, and hyper-
arousal, and with PTSD total symptom score (23,24,26). In a single
stress rat model, increased neuronal apoptosis has been observed
in the medial prefrontal cortex (mPFC) 7 days after stress expo-
sure indicating that apoptotic-related molecules are sensitive to
traumatic stress (27). Emerging data indicate that TNF and the
anti-apoptotic protein Bcl-2 exert a neuroprotective effect in the
brain against traumatic stress (28–30).
Using network analysis, current results reveal for the first time
that the 15 genes of the inflammatory pathway in the amygdala
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Table 2 | Upregulated genes in amygdala (14 days after stress).
No Gene Names of genes listed in Genecards Fold change Significance
Stress/CON Log(2) p FDR
1 RASA3 Ras GTPase-activating protein 3 2.02 1.01 0.0040 0.0091
2 Dusp3 Dual specificity protein phosphatase 3 2.03 1.02 0.0107 0.0163
3 Gucy1a2 Guanylate cyclase 1, soluble, alpha 2 2.05 1.03 0.0023 0.0071
4 Grik2 Glutamate receptor, ionotropic, kainate 2 2.06 1.04 0.0012 0.0047
5 Mrps28 Mitochondrial ribosomal protein S28 2.21 1.14 0.0143 0.0199
6 Got2 Glutamic-oxaloacetic transaminase 2 2.27 1.18 0.0077 0.0133
7 Gucy2f Guanylate cyclase 2F, retinal 2.34 1.23 0.0075 0.0133
8 Atp5c1 ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 11 2.36 1.24 0.0111 0.0165
9 Akap1 A-kinase anchor protein 1 2.39 1.25 0.0098 0.0155
10 Idh3a Isocitrate dehydrogenase 3 (NAD+) alpha 2.57 1.36 0.0034 0.0088
11 Cox8a Cytochrome c oxidase subunit VIIIA (ubiquitous) 2.61 1.38 0.0024 0.0071
12 Cpt1b Carnitine palmitoyltransferase 1B (muscle) 2.80 1.49 0.0074 0.0133
13 Atp5f1 ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1 3.02 1.59 0.0002 0.0029
14 mt-Tw Mitochondrially encoded tRNA tryptophan 3.18 1.67 0.0011 0.0047
15 Kif5b Kinesin family member 5B 3.21 1.68 0.0147 0.0199
16 CTSD Cathepsin D 3.30 1.72 0.0017 0.0055
17 Nrg1 Neuregulin 1 3.34 1.74 0.0006 0.0044
18 mt-Ty Mitochondrially encoded tRNA tyrosine 3.44 1.78 0.0011 0.0047
19 Timm9 Translocase of inner mitochondrial membrane 9 homolog 3.49 1.80 0.0011 0.0047
20 Rab8a Member RAS oncogene family 3.54 1.82 0.0000 0.0014
21 Rasgrp4 RAS guanyl releasing protein 4 3.62 1.86 0.0008 0.0047
22 mt-Tk Mitochondrially encoded tRNA lysine 3.69 1.88 0.0006 0.0044
23 mt-Rnr1 Mitochondrially encoded 12S RNA1 4.05 2.02 0.0001 0.0024
24 Camk2g Calcium/calmodulin-dependent protein kinase II gamma 4.13 2.05 0.0032 0.0086
25 Grin3b Glutamate receptor, ionotropic, N -methyl-d-aspartate 3B protein 4.77 2.25 0.0016 0.0055
26 Itpk1 Inositol 1,3,4-trisphosphate 5/6 kinase2 5.59 2.48 0.0006 0.0044
27 Csf2rb Colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) 6.11 2.61 0.0005 0.0044
28 Tmlhe Trimethyllysine hydroxylase, epsilon 6.71 2.75 0.0007 0.0045
29 Arntl2 Aryl hydrocarbon receptor nuclear translocator-like 2 7.86 2.97 0.0001 0.0028
30 Mutyh mutY homolog (E. coli ) 7.92 2.99 0.0141 0.0199
31 Rap1b Ras family small GTP binding protein RAP1B2 10.13 3.34 0.0014 0.0053
32 Lonp1 Lon peptidase 1, mitochondrial 12.04 3.59 0.0016 0.0055
33 Grpel2 GrpE-like 2, mitochondrial (E. coli ) 13.49 3.75 0.0009 0.0047
34 mt-Td Mitochondrially encoded tRNA aspartic acid 14.17 3.82 0.0032 0.0086
complex are up- or downregulated in the exaggerated fear response
(Figure 4). These inflammatory signaling molecules may partici-
pate in the evolution of PTSD to a chronic disorder because they
remain up- or downregulated 14 days after the stress protocol.
Bcl-2, an integral outer mitochondrial membrane protein, was ini-
tially found to block the apoptotic death of lymphocytes, and over
expression of Bcl-2 in transgenic mice reduced the fear response
(31, 32). In the current stress model of PTSD, the expression
of Bcl-2 is downregulated in the amygdala, indicating that both
neuronal inflammatory and cellular apoptosis signaling pathways
contribute to the exaggeration of fear following traumatic stress.
The network analysis encourages future studies to detail the cel-
lular mechanisms that are evidenced to underlie PTSD (4, 5, 27,
33). For example, the Bcl-2 mediated apoptotic cellular process
may contribute not only to the degenerated amygdala structure
in PTSD patients but also to the impairment of the controlling
function of the amygdala in the fear response of PTSD patients.
This process may also be observable in animal models of PTSD
(27, 34–36).
Among the downregulated genes, the basic helix–loop–helix
transcription genes, BHLHE, have been associated with symptoms
of PTSD such as sleep disturbance. For example, BHLHE40 and
BHLHE41 are mainly expressed in the suprachiasmatic nucleus
of the hypothalamus, which governs circadian rhythm (37).
BHLHE40 synchronizes the circadian rhythm at the intracellular
level with the external light–dark cycle. The current study demon-
strates for the first time that downregulated BHLHE40 expression
in the amygdala is associated with exaggerated fear following trau-
matic stress. Thus BHLHE40 may be a target for treatment of the
disruption of sleep associated with PTSD, a symptom that is often
resistant to present pharmacotherapy. Changes in the light/dark
cycle have also been shown to disrupt memory of conditioned
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FIGURE 3 | In (A), IPA associates stress reregulated mitochondrial-
related genes with the network containing Bcl-2 andTNF are shown.
(B) is a bar graph plotted as mean±SD of the intensity of up- or
downregulated genes in the stressed (n=10) and control amygdala
(p<0.01, n=10) for the network associated with Bcl-2 and TNF in the
amygdala 14 days after stress. The order is plotted according to fold
change, from downregulated with lowest negative value to upregulated
with highest positive value.
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FIGURE 4 | Node (gene) and edge (gene relationship) symbols are
described in the figure. The intensity of the node color-(red ) indicates the
degree of upregulation. Genes in uncolored nodes are not identified as
differentially expressed genes in our experiment and are integrated into the
computationally generated networks on the basis of the evidence stored in
the IPA knowledge memory indicating a relevance to this network. The
node shapes denote enzymes, phosphatases, kinases, peptidases,
G-protein-coupled receptors, transmembrane receptors, cytokines, growth
factors, ion channels, transporters, translation factors, nuclear receptors,
and transcription factors.
fear (38–40). Thus, the circadian system may relate to anxiety and
altered cognition following traumatic stress.
In addition to the Hub molecules such as Bcl-2 and TNF in
the inflammatory and apoptotic pathways, other up- or down-
regulated gene products in the pathways could contribute to the
exaggerated fear response. Although little has been published asso-
ciating these molecules with exaggerated fear or other PTSD symp-
toms, they have been related to neuronal regulation. For example,
GDF-15 is a potent trophic factor in the recovery of 6-OHDA-
lesioned midbrain dopaminergic neurons (41). Downregulation
of GDF-15 may jeopardize neuronal survival in the amygdala fol-
lowing traumatic stress. Mitochondrial carrier homolog 1 (Mtch1)
is an outer mitochondrial membrane protein and overexpres-
sion of Mtch1 causes mitochondrial depolarization and apoptosis,
likely via the permeability transition pore (42). Egr transcrip-
tional regulators such as Egr1 have been widely recognized as
molecules essential for emotional learning and memory (43, 44).
Moreover, Egr1-deficient mice have impairments in late phase
hippocampal LTP and consolidation of some forms of amygdala-
dependent memory through a protein phosphatase calcineurin-
mediated mechanism (43, 44). Thus, downregulated Egr1 follow-
ing traumatic stress may impair cellular processes associated with
emotional learning.
TRAUMATIC STRESS UP- AND DOWNREGULATED GENES IN THE
AMYGDALA ASSOCIATED WITH SUICIDE
Post-traumatic stress disorder significantly increases risk for sui-
cide, even after adjusting for depression, which is often comorbid.
Therefore, it appears that traumatic stress exposure and its con-
sequences are risk factors for suicide in some people (45, 46).
Correlation of mechanisms underlying suicide anxiety can help in
understanding the cellular and molecular connections between
these two mental disorders. Using molecular network analysis
of genes up- or downregulated by traumatic stress, as shown in
Figure 2 and Tables 1 and 2, genes including TUBA1, CTSD, and
Grik2 have been associated with suicidal events (47, 48). Dysreg-
ulation of each of these genes produces profound damage to the
brain.
Mutations of TUBA1A in this gene cause lissencephaly type 3
(LIS3), a neurological condition characterized by microcephaly,
mental retardation, early-onset epilepsy, and defective neuronal
migration (49). TUBA1 is also an interacting cytoskeleton protein
that has a functional connection to glutamate, GABA, and sero-
tonin receptors (48). Mutations in the CTSD gene are involved in
the pathogenesis of AD and Niemann–Pick disease (50–53).
A recent proteomic study on post mortem brains of suicide vic-
tims shows that both TUBA1A and CTSD are highly expressed in
the prefrontal cortex and amygdala of suicide victims, suggesting
that these genes may be a risk biomarker for suicide (48). As shown
in Figure 4, S100 Calcium Binding Protein A1 (S100A1; one of the
proteins in the super family of S100, also called P11) interacts with
TUBA1A and may regulate the function of TUBA1 under stressful
conditions (54). In fact, in a recent clinical study, the mRNA level
of S100A10 was found to be a potential adjunctive biomarker for
the assessment of suicide risk in anxiety disorders (55).
Kainate receptors are members of the ionotropic class of gluta-
mate receptors and are highly expressed in the amygdala neuronal
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FIGURE 5 | In (A), IPA associates stress up- or downregulated
mitochondrial-related genes with the network containingTP53, PPARA,
and HTT. (B) is a bar graph plotted with mean±SD of the intensity of up- or
downregulated genes for the stressed (n=10) and control amygdala
(p<0.01, n=10) in the network associated with TP53, PPARA, and HTT in the
amygdala 14 days after stress. The order is plotted according to fold change,
from downregulated with lowest negative value to upregulated with highest
positive value.
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FIGURE 6 | In (A), IPA associates stress up- or downregulated
mitochondrial-related genes with the network containing LEP and CL1.
(B) is a bar graph plotted with mean±SD of the intensity of up- or
downregulated genes for the stressed (n=10) and controlled amygdala
(p<0.01, n=10) in the network associated with LEP and CL1 in the
amygdala 14 days after stress. The order is plotted according to fold change,
from downregulated with lowest negative value to upregulated with highest
positive value.
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FIGURE 7 | In (A), IPA associates stress reregulated mitochondrial-
related genes with the network containing NFkb, Akt, and Histone 3.
(B) is a bar graph plotted with mean±SD of the intensity of up- or
downregulated genes for the stressed (n=10) and controlled amygdala
(p<0.01, n=10) in the network associated with NFkb, AKt, and Histone 3
in the amygdala 14 days after stress. The order is plotted according to fold
change, from downregulated with lowest negative value to upregulated with
highest positive value.
www.frontiersin.org September 2014 | Volume 5 | Article 164 | 11
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Li et al. Amygdala mitochondrial genes for fear
circuitry (56–60). These kainate receptors have been identified
both pre- and post-synaptically. They modulate inhibitory and
excitatory postsynaptic currents in the basolateral amygdala cir-
cuitry and play a role in synaptic plasticity associated with emo-
tional learning and memory (56–60). Thus upregulated Grik2 and
Grik genes, as found in the current study, may participate in the
emotional hyperarousal following traumatic stress. In addition,
recent pharmacogenomic studies of antidepressant treatment-
emergent suicidal events report associations with polymorphisms
of Grik2 receptor genes in depressed patients (47). The network
analysis from the present results suggests that the pharmacologic
agents that target specific subtypes of kainate receptors may be
therapeutic medications for the treatment of PTSD with suicidal
ideation.
In summary, network analysis reveals that signaling path-
ways associated with TUBA1A, CTSD, and Grik2 are poten-
tial biomarkers and therapeutic targets for PTSD with suicidal
ideation.
UP/DOWNREGULATION OF GENES IN THE AMYGDALA SUBSERVING
ENERGY PRODUCTION AND NEUROTRANSMITTER SYNTHESIS
Diminished interest and participation in activities along with
detachment and lack of positive emotions may be seen in PTSD
as energy loss or mental fatigue. This decreased energy is a
common complaint of service members after repetitive trau-
matic stress, including PTSD and TBI (61). While the mecha-
nisms underlying the mental fatigue are speculated to be due
to a shortage of energetic molecules in the brain, the detailed
mechanism remains elusive. The relationship between mitochon-
drial gene expression in the amygdala and exaggerated fear pro-
vides an approach to the cellular and molecular basis of mental
fatigue after trauma. As shown in Figure 5, two citrate cycle
genes, Idh3a and Cpt1b, were upregulated. Idh3a promotes ATP
production by catalyzing the oxidative decarboxylation of isoc-
itrate to 2-oxoglutarate. Cpt1b generates ATP from lipids via
beta-oxidation of fatty acids (62–64). Expression of ATP5C1 is
enhanced. ATP5C1 is the mitochondrial membrane ATP syn-
thase. Suppression of the ATP5C1 gene caused a decrease in cell
proliferation and ATP production (65). Enhanced expression of
ATP5C1 may suggest an enhanced demand for energy in the
amygdala in response to traumatic stress associated with exagger-
ated fear. Indeed, enhanced expression of ATP5C1 was also found
in the prefrontal cortex of PTSD postmortem brains, indicating
that the ATP5C1 gene could be a biomarker for the diagnosis of
PTSD (4).
Mitochondrial genes supporting biosynthesis are differentially
regulated under conditions of stress. Got2, which is involved in
arginine, tyrosine, and tryptophan biosynthesis, is upregulated;
Acot1 and Bcat2, two enzymes involved in fatty acid metabolism,
as well as synthesis of valine, leucine, and isoleucine, and degra-
dation of lysine, are downregulated. Tryptophan is a precursor
of serotonin, which is thought to contribute to emotional well-
being and is related to depression, which is highly comorbid with
PTSD (66, 67). In addition, selective serotonin reuptake inhibitors
(SSRIs) are a first line treatment for PTSD.
These results indicate that altered regulation of expression of
genes involved with energy production and biosynthesis in the
amygdala may be associated with the diminished interest, overall
mental fatigue, and comorbid symptoms of depression in PTSD.
UP/DOWNREGULATION OF GENES IN THE AMYGDALA ASSOCIATED
WITH IMMUNE MEDIATORS AND ENERGY EXPENDITURE
Proinflammatory chemokines have been suggested to be involved
in chronic stress, major depressive disorder, panic disorder, and
PTSD (68–73). The chemokines IL4 and CCL13 are intercon-
nected with the up- and downregulated genes shown in the net-
work 3, including Lonp1, ATP5F1, Rab8A, and Gucy2F. Levels
of chemokines including IL4, IL2, and TNF alpha in the plasma
have been found to be significantly altered in some patients suf-
fering from traumatic stress, including those with PTSD and
those suffering from child abuse (74). CCL13 is a chemotactic
cytokine that regulates leukocyte migration through interactions
with G-protein-coupled receptors (75, 76).
The up- and downregulated genes shown in the network
(Figure 6) are connected with Leptin (LEP), which is a key medi-
ator in the regulation of food intake, body weight, and possibly
memory. Dysregulation of LEP could be involved in the weight
loss resulting from chronic and repetitive stress in our rat model
of PTSD (11, 13, 77). Weight loss is a common symptom of
depression, highly comorbid with PTSD. Indeed, elevated serum
LEP levels were found in PTSD patients suffering from depressive
symptoms caused by earthquakes and myocardial infarctions (78,
79). In addition, intraperitoneal injection of LEP mitigated the
impairment of fear memory in the mouse deprived of rapid eye
movement sleep (80). Thus, it appears that the elevation of LEP in
patients with PTSD may be associated with elevated fear, similar
to an observation made in the current rat model of PTSD.
UP/DOWNREGULATION OF GENES IN THE AMYGDALA ASSOCIATED
TRANSCRIPTION FACTORS AND CHROMATIN REMODELING
As indicated in the signaling pathway shown in Figure 7, four
genes, including neuregulin 1 (Nrg1), calmodulin-dependent
kinases 2 gamma (Camk2g), tubuline (Tuba1A), and the A-kinase
anchor protein 1 (AKAP1), are upregulated in the amygdala
14 days after stress, and E-twenty six (ETS) domain-containing
transcription factor (ELK3) is downregulated. In addition to
the functions of the individual up- or downregulated genes in
Figure 7, these genes are interconnected with histone 3 and his-
tone 4. Histone H3 and histone H4 are two of the five main histone
proteins involved in the structure of chromatin in eukaryotic cells.
Thus, the up- or downregulated genes in the network appear to
affect transcription and chromatin remodeling.
Regulation of chromatin structure through post-translational
modification of histone proteins is a critical step in the formation
of long-term memory (81). As revealed in the network analy-
sis, traumatic and repetitive stress leads to altered regulation of
chromatin-related genes in the amygdala, including the upreg-
ulation of Nrg1, CamK2g, Tuba1A, and AKAP1, as well as the
downregulation of ELK3 interacting with NF-kappa B, histone 3,
and histone 4. Histone 3 and histone 4 drive epigenetic modifica-
tions and conformational changes in chromatin, stimulating the
expression of neuroplasticity-related genes involved in traumatic
memory and fear learning (82, 83). Histone acetylation mediated
by BDNF gene transcription is involved in the consolidation of
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fear memory associated with an animal model of PTSD (84). This
modulation could promote chromatin remodeling in the amyg-
dala induced by glucocorticoids following traumatic stress. Indeed,
activation of the glucocorticoid receptor (GR) under stress has also
been shown to modify chromatin structure by post-translational
modifications of histones and is considered to be a new therapeutic
target for PTSD (85, 86).
Nuclear factor kappa-light-chain-enhancer of activated B
cells (NF-κB), a protein complex that controls the transcrip-
tion of DNA, interacts with up- or downregulated genes in
network 4. Inhibition of NF-κB in the basolateral amygdala
impairs the memory reconsolidation associated with auditory fear
conditioning (87).
SUMMARY
The current study reveals that multiple signaling networks are up-
or downregulated in the amygdala circuitry 14 days after trau-
matic stress. Traumatic stress significantly alters at least 55 genes
associated with at least four pathways related to mitochondria
functions in the stressed amygdala. These molecules include well-
studied and -documented networks as well as novel networks that
have not been well documented in previous literature. These find-
ings provide a guide for further studies associated with diagnostic
biomarkers, therapeutic molecular targets, and identification of
optimal strategies for fostering resilience before and after trau-
matic stress. In addition, current analyses suggest new targets for
pharmacological intervention to treat PTSD and suicide. Suicide-
related genes revealed in the stressed amygdala indicate that dys-
regulated signaling pathways interweave suicide and fear. These
results elucidate the molecular pathways underlying PTSD as a
road to diagnosis and treatment.
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